Overview of recommended indicators for routine monitoring of iCCM

Slides:



Advertisements
Similar presentations
Reporting Requirements and Indicators for Supply Chain Management of HIV Diagnostics & Medicines: Kenya and Nigeria Yasmin Chandani, Coordinator for HIV/AIDS.
Advertisements

Improving data to improve iCCM programs: Implementation of a data quality and use package in Malawi Presenter: Emmanuel Chimbalanga, Save the Children.
Routine data systems related to case management Mac Otten Surveillance, Monitoring, and Evaluation Global Malaria Programme, WHO.
Monitoring & Evaluation for Routine Immunization: Data For Action
Introduction to Monitoring and Evaluation for National TB Programs 20 September 2005.
Module 2: Basic analyses. Module 2: Learning Objectives  Identify approaches for setting targets  Understand common analyses that calculate program.
Indicators, Data Sources, and Data Quality for TB M&E
World Health Organization
Dr. Richard B. Munyaneza, MD, Rwanda Ministry of Health.
1 Interpretation and use. 2 The walls inside are plastered with laboriously made graphs…
Community-Based Treatment of Pneumonia (“CBT of P”) Technical basis, USAID strategy and the role of PVOs Child Survival and Health PVO Grants RFA Orientation.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Option B+ Weekly SMS reporting; data Use to improve service delivery Zikulah Namukwaya, MD, MPH MU-JHU Care /Mulago Hospital AIDS 2014 – Stepping Up The.
Assessing the Feasibility of Continuous Net Distribution in Kenya using Community Based Approach.
CHAPTER V Health Information. Updates on new legislation (1)  Decision No.1605/2010/QĐ-TTg approving the National Program for Application of information.
HIV/AIDS BI-ANNUAL REVIEW 2008 Monitoring, Evaluation, Research and Review of the NMSF - goals and indicators Dr Andrew Kitua, NIMR.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Integrated Management of Childhood Illnesses
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
Going mobile to get data used Lessons from the development of mobile data collection systems Bram Piot, Aleck Dhliwayo, Marie Solange Ngoueko Evaluation.
Session 5: Selecting and Operationalizing Indicators.
Page 1 The Role of Community Health Workers The Key to Progress in Delivering Care to the Poorest of the Poor Eric Swedberg Child Health & Nutrition Advisor.
Definition of indicators Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
TECHNICAL Review: M&E Strategy and Indicators DR HARRIET KIVUMBI, PUBLIC HEALTH SPECIALIST, ACCESS-SMC.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
Every day. In times of crisis. For our future. Dr. Kechi Achebe, Senior Director HIV/AIDS & TB Integrated Community Case Management - One Opportunity for.
Introduction to Monitoring and Evaluation of National Tuberculosis Programs Lisa V. Adams, MD E&E Regional Workshop Kiev, Ukraine May 23-26, 2006.
New WHO Guidelines on Person centred monitoring
Fracture Liaison Service Database
iCCM Recommended Indicators
Integrated Monitoring and Supervision Approaches The Gambia
Integrating ICCM in NHIS NIGER
ETHIOPIA National iCCM Plan/strategy, key components and implementation challenges in Ethiopia February 2016 Nairobi Kenya.
Zimbabwe’s shift towards treat all: national country context
Development of the detailed Nutrition Response Plan
Experiences from Scaling up iCCM in Uganda:
Procurement and Supply Management for iCCM – common challenges
SMC in Nigeria: current status & lessons learnt
A Scalable Model for Community Health Worker Motivation
iCCM Experience Malawi
Zambia iCCM Experience
Monitoring and Evaluation Systems for NARS Organisations in Papua New Guinea Day 2. Session 6. Developing indicators.
Maternal and Child Survival Program/JSI
Harnessing m-Health and digital solutions for effective and sustainable social marketing 12th October 2017 Presenter: Emilie Chambert.
Integrated PSM for effective ICCM implementation
RAcE Malawi Final Evaluation Results
Republic of Mozambique
RAcE Niger Final Evaluation Results
Session: 4 Using the RDQA tool for Data Verification
RAcE Multi-Country Results Dissemination Meeting
SARI Information System & Data Dashboard Suriname
IX- PREPARING THE BUDGET
Find and Treat All Missing Persons with TB
Decision Framework for Prioritization of Anemia Action
Assessment Training Session 9: Assessment Analysis
Conducting Effective Mentoring Visit
Public Health Surveillance
MAMaZ Against Malaria, Zambia
Session: 6 Understanding & Using the RDQA Tool Output
A Review of Effective Teaching Skills
Improving routine data for child health in HMIS Action plan for Uganda
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Roles of District Community-Directed Intervention (CDI) Team Members
Indicators, Data Sources and Data Quality for TB M&E
TRACE INITIATIVE: Overview
Monitoring and Evaluation
Stakeholder engagement and research utilization: Insights from Namibia
How are programmes specifically designed using collected data?
Presentation transcript:

Overview of recommended indicators for routine monitoring of iCCM Tanya Guenther Advisor M&E and HMIS, Save the Children Kate Gilroy Advisor, MMEL MSCP/JSI

Process to Review and Refine iCCM indicators for Routine Monitoring The M&E sub group of the global CCM Task Force started a process in Aug 2015 of reviewing the indicators and defining routine data needs at every level of iCCM implementation Developed an initial list of indicators and criteria for prioritizing the routine indicators

Process to Review and Refine iCCM indicators for Routine Monitoring Feedback on list of proposed indicators sought from other CCM TF subgroups and the Steering Committee – representing a wide range of partners supporting iCCM. The sub group has proposed a set of 10 indicators in 6 domains to be collected through routine systems: The sub group urges countries to identify opportunities to include these high value iCCM indicators in the DHIS or other national HMIS. Human Resources (3) Service Delivery (3) Supply Chain (1) Referrals (1) Reporting (1) Clinical coaching (1)

Routine Indicators: Human Resources Catchment population per ICCM CHW: Total population and estimated # of children under five per CCM site iCCM program coverage for target population: Percentage of target communities (target population) with access to iCCM services CHW to supervisor ratio: Ratio of CHWs deployed for CCM to CCM supervisors Measurement notes: Data collected/updated annually Countries to define eligibility of target communities for iCCM Requires information on CHW and CHW supervisor training and deployment and population data for target communities

Routine Indicators: Service Delivery iCCM case load by CHW: Average number of cases under five years of age seen for iCCM by CHW by report period iCCM treatment rate: Number of ** cases under five years of age treated by CHWs per 1,000 children under five years of age in target areas in a given time period RDT+ Malaria Suspected Pneumonia (cough or difficulty breathing with a high respiratory rate for age) Diarrhea (can report ORS, zinc and ORS+zinc) Severe Acute Malnutrition Moderate Acute Malnutrition RDT positivity rate: Percentage of fever cases under five years of age presenting to CHW who were tested with RDT and received a positive result Measurement notes: CCM treatment rate indicators enable routine assessment of utilization in iCCM target areas. Should be examined in comparison with the expected number of cases to draw inferences about estimated coverage of CHW treatment   Only recommended where CHWs are treating SAM and MAM

Routine Indicators: Supply Chain Medicine and diagnostic availability: percentage of CHWs with all key iCCM medicines and diagnostics in stock on last day of reporting period low osmolarity ORS and zinc supplements for diarrhea amoxicillin for pneumonia ACTs and RDTs (where appropriate) for fever/malaria in malaria-endemic countries others required by program (tailor to each country’s needs) Measurement notes: SC group recommends countries work toward capturing continuous stock availability (% of CHWs with no stockouts in the past month) to gain a more complete picture of product availability Countries may opt to identify 1-2 items as ‘tracers’ to limit reporting burden and focus attention

Routine Indicators: Referrals Referral rate: number of iCCM cases under five years of age recommended for referral by the CHW per 100 iCCM cases under five years of age seen by CHW Measurement notes: Reasons for referral will often include danger signs or stock-outs No ‘benchmark’ value exists; countries need to establish range and follow-up to determine reasons behind low or high values Does not capture how well CHWs identify danger signs, whether referrals are made correctly, nor whether the referred child is actually taken to a health facility for care Special studies are recommended to better understand referral

Routine Indicators: Reporting Reporting level: percentage of expected reports with iCCM data received during time period Measurement notes: Disaggregate by level (CHW, health facility, district) Does not provide information on the timeliness or quality of the data nor whether the data are being used by district, facility staff or CHWs to inform decision-making about CCM programs. Countries using DHIS2 may be able to track whether reports were received by reporting date Periodic data quality audits are recommended to evaluate data quality and identify areas for improvement

Routine Indicators: Clinical Coaching Clinical coaching/mentorship: percentage of CHWs who received clinical coaching/mentorship* in iCCM during reporting period; * - to be defined locally' Measurement notes: Definition of clinical mentorship/coaching activities will need to be determined by countries. Clinical mentorship and coaching activities are those that review and discuss the CHW quality of services and quality and accuracy of data completeness Does not provide information on the quality of the mentorship or coaching, nor does it indicate whether the treatment of the sick child was considered appropriate

Next Steps M&E subgroup is close to finalizing indicator reference sheets that provide detailed information on definition, rationale, data sources and methods, interpretation and caveats. Will disseminate online and through meetings, conferences, workshops etc. Working to develop supporting tools (e.g. sample registers and reports; DHIS2 dashboards and visualization aids) Collaborating with other global initiatives to harmonize recommended indicators at community level (Global Data Collaborative, Global Fund, etc.) Please send your comments on these recommended indicators to kate_gilroy@jsi.com